Načítá se...

Recombinant T Cell Receptor Ligand (RTL) Treats Experimental Stroke

BACKGROUND AND PURPOSE: Experimental stroke induces a biphasic effect on the immune response that involves early activation of peripheral leukocytes followed by severe immunodepression and atrophy of spleen and thymus. In tandem, the developing infarct is exacerbated by influx of numerous inflammato...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Subramanian, Sandhya, Zhang, Bing, Kosaka, Yasuharu, Burrows, Gregory G., Grafe, Marjorie R., Vandenbark, Arthur A., Hurn, Patricia D., Offner, Halina
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2704258/
https://ncbi.nlm.nih.gov/pubmed/19443805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.108.543991
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!